NCT00002943View on ClinicalTrials.gov

Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

February 28, 1993

Primary Completion Date

October 31, 2003

Study Completion Date

August 31, 2007

Conditions
Extragonadal Germ Cell TumorOvarian CancerTesticular Germ Cell TumorUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

carboplatin

DRUG

cyclophosphamide

DRUG

etoposide

PROCEDURE

autologous bone marrow transplantation

Trial Locations (1)

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER